Checkpoint Therapeutics
Why Robinhood?
You can watch CKPT and buy or sell other stocks, ETFs, and their options commission-free!About CKPT
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.
CKPT Key Statistics
Stock Snapshot
As of today, Checkpoint Therapeutics(CKPT) shares are valued at $4.26. The company's market cap stands at 356.83M, with a P/E ratio of -3.78.
Checkpoint Therapeutics(CKPT) stock opened on 2026-03-10 at —. The price climbed to — and dipped to —.
Checkpoint Therapeutics(CKPT) shares are trading with a volume of 0, against a daily average of 2.9M.
In the last year, Checkpoint Therapeutics(CKPT) shares hit a 52-week high of $4.50 and a 52-week low of $1.80.
In the last year, Checkpoint Therapeutics(CKPT) shares hit a 52-week high of $4.50 and a 52-week low of $1.80.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.